Ascendis Pharma A (ASND) Return on Invested Capital (2021 - 2026)

Ascendis Pharma A (ASND) has 6 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital fell 442.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (down 442.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital grew to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 5.02% in Q4 2024 to a low of 0.05% in Q3 2022.
• A 5-year average of 1.05% and a median of 0.01% in 2024 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital soared 503 bps in 2024 and tumbled 502 bps in 2025, its largest moves.
• Tracing ASND's Return on Invested Capital over 5 years: stood at 0.02% in 2022, then surged by 56 bps to 0.01% in 2023, then jumped by 62708 bps to 5.02% in 2024, then tumbled by 100 bps to 0.0% in 2025, then soared by 115 bps to 0.0% in 2026.
• Business Quant data shows ASND's Return on Invested Capital at 0.0% in Q1 2026, 0.0% in Q4 2025, and 4.27% in Q3 2025.